CA1130305A - Process for the preparation of n,n'-disubstituted 2-naphthaleneethanimidamide and intermediates used therein - Google Patents
Process for the preparation of n,n'-disubstituted 2-naphthaleneethanimidamide and intermediates used thereinInfo
- Publication number
- CA1130305A CA1130305A CA330,828A CA330828A CA1130305A CA 1130305 A CA1130305 A CA 1130305A CA 330828 A CA330828 A CA 330828A CA 1130305 A CA1130305 A CA 1130305A
- Authority
- CA
- Canada
- Prior art keywords
- formula
- carbon atoms
- naphthylacetonitrile
- hydroxy
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- LHYUMRWJTVKTPD-UHFFFAOYSA-N 2-naphthalen-2-ylethanimidamide Chemical class C1=CC=CC2=CC(CC(=N)N)=CC=C21 LHYUMRWJTVKTPD-UHFFFAOYSA-N 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 title claims description 28
- 238000002360 preparation method Methods 0.000 title claims description 9
- 239000000543 intermediate Substances 0.000 title description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 22
- -1 imido ester salt Chemical class 0.000 claims abstract description 17
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 13
- 150000002825 nitriles Chemical class 0.000 claims abstract description 11
- 238000006136 alcoholysis reaction Methods 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 125000004432 carbon atom Chemical group C* 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 125000005843 halogen group Chemical group 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 150000003973 alkyl amines Chemical class 0.000 claims description 6
- 239000012458 free base Substances 0.000 claims description 6
- LPCWDVLDJVZIHA-UHFFFAOYSA-N 2-naphthalen-2-ylacetonitrile Chemical compound C1=CC=CC2=CC(CC#N)=CC=C21 LPCWDVLDJVZIHA-UHFFFAOYSA-N 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- GTTGADPSPVSIJG-UHFFFAOYSA-N ethyl 2-naphthalen-2-ylethanimidate;hydrochloride Chemical compound Cl.C1=CC=CC2=CC(CC(=N)OCC)=CC=C21 GTTGADPSPVSIJG-UHFFFAOYSA-N 0.000 claims description 4
- 229910000039 hydrogen halide Inorganic materials 0.000 claims description 3
- 239000012433 hydrogen halide Substances 0.000 claims description 3
- 239000012442 inert solvent Substances 0.000 claims description 3
- 125000001624 naphthyl group Chemical group 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims 3
- RFZXGFNZXUATFO-UHFFFAOYSA-N 2-(1-chloronaphthalen-2-yl)acetonitrile Chemical compound C1=CC=C2C(Cl)=C(CC#N)C=CC2=C1 RFZXGFNZXUATFO-UHFFFAOYSA-N 0.000 claims 1
- VCLZSWDXZNYUQB-UHFFFAOYSA-N 2-(1-hydroxynaphthalen-2-yl)acetonitrile Chemical compound C1=CC=C2C(O)=C(CC#N)C=CC2=C1 VCLZSWDXZNYUQB-UHFFFAOYSA-N 0.000 claims 1
- CHVSJQVTEBQKJL-UHFFFAOYSA-N 2-(3-methylnaphthalen-2-yl)acetonitrile Chemical compound C1=CC=C2C=C(CC#N)C(C)=CC2=C1 CHVSJQVTEBQKJL-UHFFFAOYSA-N 0.000 claims 1
- PWWQFJOWVJPYCO-UHFFFAOYSA-N 2-(6-hydroxynaphthalen-2-yl)acetonitrile Chemical compound C1=C(CC#N)C=CC2=CC(O)=CC=C21 PWWQFJOWVJPYCO-UHFFFAOYSA-N 0.000 claims 1
- NLQWCQWHTQUUNU-UHFFFAOYSA-N 2-(6-methoxynaphthalen-2-yl)acetonitrile Chemical compound C1=C(CC#N)C=CC2=CC(OC)=CC=C21 NLQWCQWHTQUUNU-UHFFFAOYSA-N 0.000 claims 1
- MZBXTJHQWBYBAL-UHFFFAOYSA-N 2-(6-methylnaphthalen-2-yl)acetonitrile Chemical compound C1=C(CC#N)C=CC2=CC(C)=CC=C21 MZBXTJHQWBYBAL-UHFFFAOYSA-N 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 3
- 230000001430 anti-depressive effect Effects 0.000 abstract description 2
- 239000000935 antidepressant agent Substances 0.000 abstract description 2
- 229940005513 antidepressants Drugs 0.000 abstract description 2
- 210000003169 central nervous system Anatomy 0.000 abstract description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 230000000875 corresponding effect Effects 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 125000004494 ethyl ester group Chemical group 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 5
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229960005419 nitrogen Drugs 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- FJSKXQVRKZTKSI-UHFFFAOYSA-N 2,3-dimethylfuran Chemical compound CC=1C=COC=1C FJSKXQVRKZTKSI-UHFFFAOYSA-N 0.000 description 1
- AGWQKZPRUWXKEH-UHFFFAOYSA-N 2-(6-hydroxynaphthalen-2-yl)acetamide hydrochloride Chemical compound Cl.C1=C(O)C=CC2=CC(CC(=N)O)=CC=C21 AGWQKZPRUWXKEH-UHFFFAOYSA-N 0.000 description 1
- ZGWMCFXMLOKXTN-UHFFFAOYSA-N 2-(6-methoxynaphthalen-2-yl)acetamide hydrochloride Chemical compound Cl.C1=C(CC(O)=N)C=CC2=CC(OC)=CC=C21 ZGWMCFXMLOKXTN-UHFFFAOYSA-N 0.000 description 1
- VLHPLJIWMWWTBN-UHFFFAOYSA-N 2-(6-methylnaphthalen-2-yl)acetamide hydrochloride Chemical compound Cl.C1=C(CC(O)=N)C=CC2=CC(C)=CC=C21 VLHPLJIWMWWTBN-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- LXTQGYPVTFADHK-UHFFFAOYSA-N Cl.C1=C(C=CC2=CC=CC=C12)CC(O)=N Chemical compound Cl.C1=C(C=CC2=CC=CC=C12)CC(O)=N LXTQGYPVTFADHK-UHFFFAOYSA-N 0.000 description 1
- NDDZJZXUJNRLGD-UHFFFAOYSA-N Cl.C1=CC=C2C=C(CC(O)=N)C(C)=CC2=C1 Chemical compound Cl.C1=CC=C2C=C(CC(O)=N)C(C)=CC2=C1 NDDZJZXUJNRLGD-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 102220347004 c.89G>A Human genes 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- PZYUESQIXBTVPG-UHFFFAOYSA-N ethanimidamide;naphthalene Chemical compound CC(N)=N.C1=CC=CC2=CC=CC=C21 PZYUESQIXBTVPG-UHFFFAOYSA-N 0.000 description 1
- CKEYDFOHSHJTHQ-UHFFFAOYSA-N ethyl 2-naphthalen-2-ylethanimidate Chemical compound C1=CC=CC2=CC(CC(=N)OCC)=CC=C21 CKEYDFOHSHJTHQ-UHFFFAOYSA-N 0.000 description 1
- CEIPQQODRKXDSB-UHFFFAOYSA-N ethyl 3-(6-hydroxynaphthalen-2-yl)-1H-indazole-5-carboximidate dihydrochloride Chemical compound Cl.Cl.C1=C(O)C=CC2=CC(C3=NNC4=CC=C(C=C43)C(=N)OCC)=CC=C21 CEIPQQODRKXDSB-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N hydrogen bromide Substances Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 150000002463 imidates Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- DIEOESIZLAHURK-UHFFFAOYSA-N n-naphthalen-2-ylacetamide Chemical compound C1=CC=CC2=CC(NC(=O)C)=CC=C21 DIEOESIZLAHURK-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
- C07C15/20—Polycyclic condensed hydrocarbons
- C07C15/24—Polycyclic condensed hydrocarbons containing two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C241/00—Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/04—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/04—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers
- C07C257/06—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers having carbon atoms of imino-carboxyl groups bound to hydrogen atoms, to acyclic carbon atoms, or to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
ABSTRACT
N,N'-disubstituted 2-naphthaleneethanimidamide is prepared by the conversion of a nitrile into the novel imido ester salt intermediate by alcoholysis followed by treatment of the intermediate with an alklamine to give the product. The final products display central nervous system activity e.g. antidepressant.
N,N'-disubstituted 2-naphthaleneethanimidamide is prepared by the conversion of a nitrile into the novel imido ester salt intermediate by alcoholysis followed by treatment of the intermediate with an alklamine to give the product. The final products display central nervous system activity e.g. antidepressant.
Description
The present invention is directed to a process for preparing N,N'-disubstituted 2-naphthaleneethanimidamide compounds and their pharma-ceutically-acceptable salts having the general formula (Rl) ~ CH C
(R2)m wherein R represents a loweralkyl of from 1 to 3 carbon atoms; Rl and R2 may each be located on one of the possible free positions of the naphtha-lene ring and independently represent halo, hydroxy, loweralkoxy or loweralkyl; and m and n independently represent the integers zero or one.
As used herein the terms loweralkoxy and loweralkyl refer to a moiety having from 1 to 3 carbon atoms in a chain, either branched or unbranched. The term halo refers to a halogen substitution selected from the group consist-ing of chloro, bromo, and fluoro. As used herein the term pharmaceutically-accsptable salt re~ers to an acid addition salt of the free base which is relatively innocuous to animals at dosages consis~ent with good pharmaco-dynamic activity. United States Patent 3,903,163 describes various N,N'-disubstituted 2-naphthaleneethanimidamide compounds and their pharmaceuti-cally-acceptable salts as displaying central nervous system activity.
The compounds are particularly useful as antidepressant and antianxiety agents. The active compounds were prepared by reacting 2-naphthyl-acetonitrile with a preselected primary amine and primary ammonium ion.
Alternately, the compounds vere prepared by the reaction of the corres-ponding substituted naphthylacetamide with a trialkyloxonium fluoroborate to prepare the N-alkyl substituted arylnitrilium fluoroborate salt. This was followed by the reaction of the fluoroborate salt with a primary alkylamine. Neither method of preparing the compounds was satisfactory .: - 1 -~3~305 for the production of large batches of material for commercial purposes. In carrying out the method of the present invention a compound corresponding to formula I is prepared in a two step reaction. In the first step the nitrile is converted into the corresponding imido ester salt by alcoholysis using an absolute alcohol and an anhydrous acid. In the second step the imido ester salt is treated with excess anhydrous alkylamine to give the N,N'-disubstituted napthaleneethanimidamide salt. The general reaction sequence may be re-presented as follows:
Step 1 l)n CH CN (Rl)n CH2COR3 ~ ~/ 2 ~ NH HX
~ + R30H ~ HX
~: ~ (R2)m (R2)m II III
. ~P~
:~ (Rl) ~/~ CH2CNHR
III ~ 2RNH2 ~- - ~ ~ NR-HX
~R2)m IV
wherein R, Rl, R2, n and m are as defined above, R3 is a lower alkyl generally of from one to 3 carbon atoms and X~is a halide.
The N,N'-disubstituted 2-naphthaleneethanimidamide salt ~IV) may be separated by conventional procedures such as filtering or centrifugation.
The free base may be prepared by the neutralization of the salt in an aqueous base. For example, the salt may be mixed with a molar equivalent amount of sodium hydroxide in aqueous solution, excess aqueous sodium carbonate or the like, after which the free base is separated by extraction with an organic - solvent. The salt and free base may also be further purified, if desired, ' `` ~L13~305 by using conventional procedures such as washing or recrystallization.
The present in~ention is also directed to the novel alkyl 2-naphthaleneethanimidate salts corresponding to formula III which serve as intermediates in the above reaction sequence and to a process for their preparation. Particularly preferred are compounds corresponding to formula III wherein n and m are both 0 and compounds wherein the substitutions are in the 1-, 3- or 4-position on the naphthalene moiety, of these compounds especially preferred are those bearing a chloro substitution in the 1-; position.
In the actual practice, according to step l of the above reaction a 2-naphthylacetonitrile corresponding to formula II is dissolved in a non-hydrolytic solvent, such as toluene, chloroform, or ether, and treated with ; an absolute lower alcohol such as methyl alcohol, ethyl alcohol, propyl alcohol, etc. For each equivalent of nitrile from about 1 to about 1.4 ; equivalents of alcohol are used with about 1.15 equivalents of alcohol be-ing preferred. An anhydrous pharmaceutically acceptable strong acid, generally a hydrogen halide such as hydrogen chloride or bromide, is added at such a rate that the reaction temperature does not exceed ~0C. The preferred temperature for carrying out Step 1 of the reaction is between 0 and 30C. At least one equivalent of acid is required for complete reaction and greater quantities may be added up to the saturation point without significantly affecting the reaction. The reaction is allowed ~o run until substantially all of the nitrile is converted to the imidate, generally about 15 hours. The reaction may be monitored by thin layer chromatography and the disappearance of the starting nitrile is indicative of complete reaction. The imido ester salt (III) usuall~ crystallizes from the reaction mixture and may be collected b~ filtration. The reaction should not be run above atmospheric pressure since undesirable side reactions may take place )30S
which effect the purity of the product.
Thus this invention relates to a process for the preparation of a compound of the formula:
l)n C~l2C.OR3 ~III) NH-~
~ R2)m wherein Rl and R2 are the same or different and each independently represents a halogen atom or a hydroxy group, an alkyl group of one to three carbon atoms or an alkoxy group of one to three carbon atoms; m and n are the same or dif-ferent and independently represent zero or one; R3 represents an alkyl group of one to three carbon atoms; and X represents a halogen atom; which com-prises submitting a nitrile of the formula ~ l~n~cH2cN
(II) ~R2)~
wherein Rl, R2, m and n are as previously defined, to alcoholysis using an anhydrous alkanol of one to three carbon atoms in the presence of an anhydrous hydrogen halide.
In Step 2 of the reaction sequence the imido ester salt ~III) pre-pared in Step 1 is reacted with a preselected anhydrous alkylamine in an inert solvent such as methanol, ethanol, dimethylfuran, and the like. This step may be carried out in a pressured vessel if desired. The reaction temperature is maintained at from about 45C to about 120C with from 50 to 80C being preferred. The reaction is run for a time sufficient to convert substantially all of the imido ester salt to the final product. An excess of alkylamine, '~
3~
at least two equivalents over the starting nitrile of formula II, is generally preferred to assure satisfactory yields of product.
The following examples will serve to further clarify the present invention, but are not to be construed as a limitation thereon.
Example 1: Preparation of ethyl 2-naphthaleneethanimidate hydrochloride intermediate.
The reaction vessel was charged with 40.0 grams (0.239 mol.) of 2-naphthylacetonitrile, 12.7 grams (0.274 mol.) of absolute alcohol, and 400 ml of toluene. The resulting mixture was cooled to 2C, and anhydrous hydrogen chloride was sparged in until the temperature reached 10C. A total of 17.4 grams ~0.477 mol.) of hydrogen chloride was added. After the addition was complete, the reaction mixture was stirred at 2C to 10C for about two hours.
The cooling bath was removed, and the reaction mixture allowed to warm to room temperature. The ~eaction mixture was stirred overnight during which time a white solid formed until the mixture was a thick slurry. The excess hydrogen chloride was sparged out with a stream of nitrogen. The solid was filtered off, washed with toluene, air dried, and vacuum dried to yield 57.7 grams (97% yield) of the title intermediate. The melting point was found to be 202-204C, however, the imidate salt rearranges on heating to form 2-naphthyl-acetamide.
Elemental analysis showed carbon 67.3%, hydrogen 6.70% and nitro-gen 5.62% compared to theoretical values of carbon 67.3%, hydro~en 6.46%, and nitrogen 5.61%.
Example 2: Preparation of N,N'-dimethyl 2-naphthaleneethanimidate hydrochloride In a 100 ml. reaction vessel, equipped with a stirrer, thermometer, a pressure-equalizing addition funnel, and a reflux condenser fitted with a drying tube, 11.95 grams ~0.048 mol.~ of ethyl 2-naphthaleneethanimidate 1:~303~
hydrochloride was placed~ A solution of 21.20 grams (0~683 mol.) of methyl-amine in 35 ml. of absolute ethanol was rapidly added to the reaction maxture.
The temperature quickly rose to 65C and dropped to about 30C after all of the solution was added. The reaction mixture was kept between about 50-53C
or 21 hours. The xeaction mixture was cooled to 2C and the white crystal-line product was filtered off~ The product was washed with toluene and dried to gi~e 10.2 grams (85% yield) of the title compound. The crude product was recrystallized from absolute ethanol to yield 8.97 grams of the title com-pound. The melting point was 225.5-227C
Other novel substituted imido ester salt intermediates correspond-ing to ~ormula III were also prepared using the general procedure in Example 1, These compounds are suitable or use in the process described above for the preparation of the corresponding N,N'-disubstituted 2-naphthaleneethan-imidamide. The intermediates are as follows ethyl ester l-chloro-2-naphthaleneethanimidate hydrochloride; elemental -C,H,N- calculated - 59.16, 5.32, 4,93: C~H,N - found - 57.9, 5.36, 5.08:
second analysis ~ 59.0, 5.53, 5.44 - melting at 208 degrees centigrade by di~ferential thermal analysis;
ethyl ester 6-methoxy-2-naphthaleneethanimidate hydrochloride; melts at 238-239 degrees centigrade;
ethyl ester 6-methyl-2-naphthaleneethanimidate hydrochloride; white solid, melting at 230-232 degrees C.;
ethyl ester 3-methyl-2-naphthaleneethanimidate hydrochloride; nuclear magnetic resonance-indmso-D6-delta 1.25 ppm - Triplet 3H J 7 Hert~: delta
(R2)m wherein R represents a loweralkyl of from 1 to 3 carbon atoms; Rl and R2 may each be located on one of the possible free positions of the naphtha-lene ring and independently represent halo, hydroxy, loweralkoxy or loweralkyl; and m and n independently represent the integers zero or one.
As used herein the terms loweralkoxy and loweralkyl refer to a moiety having from 1 to 3 carbon atoms in a chain, either branched or unbranched. The term halo refers to a halogen substitution selected from the group consist-ing of chloro, bromo, and fluoro. As used herein the term pharmaceutically-accsptable salt re~ers to an acid addition salt of the free base which is relatively innocuous to animals at dosages consis~ent with good pharmaco-dynamic activity. United States Patent 3,903,163 describes various N,N'-disubstituted 2-naphthaleneethanimidamide compounds and their pharmaceuti-cally-acceptable salts as displaying central nervous system activity.
The compounds are particularly useful as antidepressant and antianxiety agents. The active compounds were prepared by reacting 2-naphthyl-acetonitrile with a preselected primary amine and primary ammonium ion.
Alternately, the compounds vere prepared by the reaction of the corres-ponding substituted naphthylacetamide with a trialkyloxonium fluoroborate to prepare the N-alkyl substituted arylnitrilium fluoroborate salt. This was followed by the reaction of the fluoroborate salt with a primary alkylamine. Neither method of preparing the compounds was satisfactory .: - 1 -~3~305 for the production of large batches of material for commercial purposes. In carrying out the method of the present invention a compound corresponding to formula I is prepared in a two step reaction. In the first step the nitrile is converted into the corresponding imido ester salt by alcoholysis using an absolute alcohol and an anhydrous acid. In the second step the imido ester salt is treated with excess anhydrous alkylamine to give the N,N'-disubstituted napthaleneethanimidamide salt. The general reaction sequence may be re-presented as follows:
Step 1 l)n CH CN (Rl)n CH2COR3 ~ ~/ 2 ~ NH HX
~ + R30H ~ HX
~: ~ (R2)m (R2)m II III
. ~P~
:~ (Rl) ~/~ CH2CNHR
III ~ 2RNH2 ~- - ~ ~ NR-HX
~R2)m IV
wherein R, Rl, R2, n and m are as defined above, R3 is a lower alkyl generally of from one to 3 carbon atoms and X~is a halide.
The N,N'-disubstituted 2-naphthaleneethanimidamide salt ~IV) may be separated by conventional procedures such as filtering or centrifugation.
The free base may be prepared by the neutralization of the salt in an aqueous base. For example, the salt may be mixed with a molar equivalent amount of sodium hydroxide in aqueous solution, excess aqueous sodium carbonate or the like, after which the free base is separated by extraction with an organic - solvent. The salt and free base may also be further purified, if desired, ' `` ~L13~305 by using conventional procedures such as washing or recrystallization.
The present in~ention is also directed to the novel alkyl 2-naphthaleneethanimidate salts corresponding to formula III which serve as intermediates in the above reaction sequence and to a process for their preparation. Particularly preferred are compounds corresponding to formula III wherein n and m are both 0 and compounds wherein the substitutions are in the 1-, 3- or 4-position on the naphthalene moiety, of these compounds especially preferred are those bearing a chloro substitution in the 1-; position.
In the actual practice, according to step l of the above reaction a 2-naphthylacetonitrile corresponding to formula II is dissolved in a non-hydrolytic solvent, such as toluene, chloroform, or ether, and treated with ; an absolute lower alcohol such as methyl alcohol, ethyl alcohol, propyl alcohol, etc. For each equivalent of nitrile from about 1 to about 1.4 ; equivalents of alcohol are used with about 1.15 equivalents of alcohol be-ing preferred. An anhydrous pharmaceutically acceptable strong acid, generally a hydrogen halide such as hydrogen chloride or bromide, is added at such a rate that the reaction temperature does not exceed ~0C. The preferred temperature for carrying out Step 1 of the reaction is between 0 and 30C. At least one equivalent of acid is required for complete reaction and greater quantities may be added up to the saturation point without significantly affecting the reaction. The reaction is allowed ~o run until substantially all of the nitrile is converted to the imidate, generally about 15 hours. The reaction may be monitored by thin layer chromatography and the disappearance of the starting nitrile is indicative of complete reaction. The imido ester salt (III) usuall~ crystallizes from the reaction mixture and may be collected b~ filtration. The reaction should not be run above atmospheric pressure since undesirable side reactions may take place )30S
which effect the purity of the product.
Thus this invention relates to a process for the preparation of a compound of the formula:
l)n C~l2C.OR3 ~III) NH-~
~ R2)m wherein Rl and R2 are the same or different and each independently represents a halogen atom or a hydroxy group, an alkyl group of one to three carbon atoms or an alkoxy group of one to three carbon atoms; m and n are the same or dif-ferent and independently represent zero or one; R3 represents an alkyl group of one to three carbon atoms; and X represents a halogen atom; which com-prises submitting a nitrile of the formula ~ l~n~cH2cN
(II) ~R2)~
wherein Rl, R2, m and n are as previously defined, to alcoholysis using an anhydrous alkanol of one to three carbon atoms in the presence of an anhydrous hydrogen halide.
In Step 2 of the reaction sequence the imido ester salt ~III) pre-pared in Step 1 is reacted with a preselected anhydrous alkylamine in an inert solvent such as methanol, ethanol, dimethylfuran, and the like. This step may be carried out in a pressured vessel if desired. The reaction temperature is maintained at from about 45C to about 120C with from 50 to 80C being preferred. The reaction is run for a time sufficient to convert substantially all of the imido ester salt to the final product. An excess of alkylamine, '~
3~
at least two equivalents over the starting nitrile of formula II, is generally preferred to assure satisfactory yields of product.
The following examples will serve to further clarify the present invention, but are not to be construed as a limitation thereon.
Example 1: Preparation of ethyl 2-naphthaleneethanimidate hydrochloride intermediate.
The reaction vessel was charged with 40.0 grams (0.239 mol.) of 2-naphthylacetonitrile, 12.7 grams (0.274 mol.) of absolute alcohol, and 400 ml of toluene. The resulting mixture was cooled to 2C, and anhydrous hydrogen chloride was sparged in until the temperature reached 10C. A total of 17.4 grams ~0.477 mol.) of hydrogen chloride was added. After the addition was complete, the reaction mixture was stirred at 2C to 10C for about two hours.
The cooling bath was removed, and the reaction mixture allowed to warm to room temperature. The ~eaction mixture was stirred overnight during which time a white solid formed until the mixture was a thick slurry. The excess hydrogen chloride was sparged out with a stream of nitrogen. The solid was filtered off, washed with toluene, air dried, and vacuum dried to yield 57.7 grams (97% yield) of the title intermediate. The melting point was found to be 202-204C, however, the imidate salt rearranges on heating to form 2-naphthyl-acetamide.
Elemental analysis showed carbon 67.3%, hydrogen 6.70% and nitro-gen 5.62% compared to theoretical values of carbon 67.3%, hydro~en 6.46%, and nitrogen 5.61%.
Example 2: Preparation of N,N'-dimethyl 2-naphthaleneethanimidate hydrochloride In a 100 ml. reaction vessel, equipped with a stirrer, thermometer, a pressure-equalizing addition funnel, and a reflux condenser fitted with a drying tube, 11.95 grams ~0.048 mol.~ of ethyl 2-naphthaleneethanimidate 1:~303~
hydrochloride was placed~ A solution of 21.20 grams (0~683 mol.) of methyl-amine in 35 ml. of absolute ethanol was rapidly added to the reaction maxture.
The temperature quickly rose to 65C and dropped to about 30C after all of the solution was added. The reaction mixture was kept between about 50-53C
or 21 hours. The xeaction mixture was cooled to 2C and the white crystal-line product was filtered off~ The product was washed with toluene and dried to gi~e 10.2 grams (85% yield) of the title compound. The crude product was recrystallized from absolute ethanol to yield 8.97 grams of the title com-pound. The melting point was 225.5-227C
Other novel substituted imido ester salt intermediates correspond-ing to ~ormula III were also prepared using the general procedure in Example 1, These compounds are suitable or use in the process described above for the preparation of the corresponding N,N'-disubstituted 2-naphthaleneethan-imidamide. The intermediates are as follows ethyl ester l-chloro-2-naphthaleneethanimidate hydrochloride; elemental -C,H,N- calculated - 59.16, 5.32, 4,93: C~H,N - found - 57.9, 5.36, 5.08:
second analysis ~ 59.0, 5.53, 5.44 - melting at 208 degrees centigrade by di~ferential thermal analysis;
ethyl ester 6-methoxy-2-naphthaleneethanimidate hydrochloride; melts at 238-239 degrees centigrade;
ethyl ester 6-methyl-2-naphthaleneethanimidate hydrochloride; white solid, melting at 230-232 degrees C.;
ethyl ester 3-methyl-2-naphthaleneethanimidate hydrochloride; nuclear magnetic resonance-indmso-D6-delta 1.25 ppm - Triplet 3H J 7 Hert~: delta
2.5 Singlet 3H: 4~3 ppm - Singlet 2H: 4,5 ppm Quartet 2H - J equals 7 HZ delta 7~25~7,~5 - Multiplet;
ethyl ester l-h~droxy 2-naphthaleneethanimidate hydrochloride; NMR in CD30D-deuteromethanol delta 1,4-Triplet 3H J equals 7 HZ: 4.2 Singlet~ 2H: 4.5 ppm .... .
~ -6-~303~S
QuartetJ 2H J equals 7 HZ: 7~2~8~2 ~ultiplet, 6H;
ethyl ester 6-hydroxy-2-naphthaleneethanimidate hydrochloride; used directly to synthesize corresponding naphthalene ethanimidamide without further characterization~
Other intermediates correspondin~ to formula III may be prepared in a similar manner.
[ ~ ~ 6a-;-
ethyl ester l-h~droxy 2-naphthaleneethanimidate hydrochloride; NMR in CD30D-deuteromethanol delta 1,4-Triplet 3H J equals 7 HZ: 4.2 Singlet~ 2H: 4.5 ppm .... .
~ -6-~303~S
QuartetJ 2H J equals 7 HZ: 7~2~8~2 ~ultiplet, 6H;
ethyl ester 6-hydroxy-2-naphthaleneethanimidate hydrochloride; used directly to synthesize corresponding naphthalene ethanimidamide without further characterization~
Other intermediates correspondin~ to formula III may be prepared in a similar manner.
[ ~ ~ 6a-;-
Claims (19)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A method for preparing an N,N'-disubstituted 2-naphthaleneethanimid-amide or a pharmaceutically-acceptable salt thereof which comprises converting a nitrile of the formula wherein R1 and R2 may each be located on one of the possible free positions of the naphthalene ring and independently represent halo, hydroxy, lower alkyl of from one to 3 carbon atoms, or lower alkoxy of from one to 3 carbon atoms, and m and n independently represent the integers zero or one, to the corresponding imido ester salt by alcoholysis using an absolute alcohol and an anhydrous pharmaceutically-acceptable strong acid at a temperature between about 0° and 40°C; reacting the imido ester salt in an inert solvent at a temperature between about 45° to 120°C with at least two equivalents of an alkylamine having the general formula wherein R is a lower alkyl of from one to 3 carbon atoms; and recovering the pharmaceutically-acceptable salt of the N,N'-disubstituted 2-naphthalene-ethanimidamide.
2. The method of Claim 1 further including neutralizing the salt and recovering the free base.
3. The method of Claim 1 wherein the conversion of the nitrile takes place at a temperature of between about 0 and 30°C.
4. The method of claims 1 or 3 wherein the imido ester salt is reacted with the alkylamino at a temperature between about 50° and 80°C.
5. A process for the preparation of a compound of the general formula (III) wherein R1 and R2 independently represent halo, hydroxy, a lower alkyl of from one to 3 carbon atoms, or a lower alkoxy of from one to 3 carbon atoms;
m and n independently represent the integer 0 or 1; R3 represents a lower alkyl of from one to 3 carbon atoms; and X represents a halogen atom, which comprises subjecting a nitrile of the formula to alcoholysis with an absolute alcohol of the formula R3OH in the presence of an anhydrous pharmaceutically-acceptable strong acid of the formula HX.
m and n independently represent the integer 0 or 1; R3 represents a lower alkyl of from one to 3 carbon atoms; and X represents a halogen atom, which comprises subjecting a nitrile of the formula to alcoholysis with an absolute alcohol of the formula R3OH in the presence of an anhydrous pharmaceutically-acceptable strong acid of the formula HX.
6. The process of claim 5 wherein n and m are both 0.
7. The process of claim 5 wherein R1 is in the 1, 3 or 4 position, n is 1, and m is 0.
8. The process of claim 7 wherein R1 is 1-chloro.
9. A process for the preparation of a compound of the formula (III) wherein Rl and R2 are the same or different and each independently represents a halogen atom or a hydroxy group, an alkyl group of one to three carbon atoms or an alkoxy group of one to three carbon atoms; m and n are the same or different and independently represent zero or one; R3 represents an alkyl group of one to three carbon atoms, and X represents a halogen atom; which comprises submitting a nitrile of the formula (II) wherein R1, R2, m and n are as previously defined, to alcoholysis using an anhydrous alkanol of one to three carbon atoms in the presence of an anhydrous hydrogen halide.
10. A process according to claim 9 in which the alcoholysis is carried out at a temperature between about 0° and 40°C.
11. A process according to claim 9 in which the compound of formula (III) obtained is reacted with at least two equivalents of an alkylamine having the general formula:
R.NH2 wherein R is an alkyl group of one to three carbon atoms, and where the acid addition salt formed can be converted into the corresponding free base.
R.NH2 wherein R is an alkyl group of one to three carbon atoms, and where the acid addition salt formed can be converted into the corresponding free base.
12. A process according to claim 1 in which the reaction is effected in an inert solvent at a temperature of between about 45° and 120°C.
13. A process according to claim 9 in which the starting material of formula II is 2-naphthylacetonitrile, 1-chloro-2-naphthylacetonitrile, 6-methoxy-2-naphthylacetonitrile, 6-methyl-2-naphthylacetonitrile, 3-methyl-2-naphthylacetonitrile, 1-hydroxy-2-naphthylacetonitrile or 6-hydroxy-2-naphthylacetonitrile.
14. A process according to claim 9 in which m and n are zero.
15. A process for the preparation of ethyl 2-naphthaleneethanimidate hydrochloride which comprises submitting 2-naphthylacetonitrile to alcoholysis with absolute ethyl alcohol containing excess anhydrous hydrogen chloride and recovering the ethyl 2-naphthaleneethanimidate hydrochloride so formed.
16. A compound of the formula (III) as defined in claim 9 whenever prepared by the process of claim 9 or by an obvious chemical equivalent there-of.
17. A compound of the formula (III) given in claim in which either m and n are both zero or (Rl)n is 1-chloro-, 6-methoxy-, 6-methyl-, 3-methyl, 1-hydroxy or 6-hydroxy and (R2)m is zero, whenever prepared by the process of claim 13 or by an obvious chemical equivalent thereof.
18. Ethyl 2-naphthaleneethanimidate hydrochloride whenever prepared by the process of claim 15 or by an obvious chemical equivalent thereof.
19. A process according to claim 15 in which the product is reacted with excess methylamine.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92169078A | 1978-07-03 | 1978-07-03 | |
US921,690 | 1978-07-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1130305A true CA1130305A (en) | 1982-08-24 |
Family
ID=25445831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA330,828A Expired CA1130305A (en) | 1978-07-03 | 1979-06-29 | Process for the preparation of n,n'-disubstituted 2-naphthaleneethanimidamide and intermediates used therein |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS559095A (en) |
AR (1) | AR230619A1 (en) |
BE (1) | BE877449A (en) |
CA (1) | CA1130305A (en) |
CH (1) | CH641764A5 (en) |
DE (1) | DE2926828A1 (en) |
DK (1) | DK273079A (en) |
ES (1) | ES482113A1 (en) |
FR (1) | FR2430414A1 (en) |
GB (1) | GB2024223B (en) |
IT (1) | IT1121792B (en) |
NL (1) | NL7904774A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4495108A (en) * | 1983-03-11 | 1985-01-22 | E. I. Du Pont De Nemours And Company | Process for preparing dialkyl propanediimidate dihydrohalides |
US5180379A (en) * | 1991-04-04 | 1993-01-19 | Minnesota Mining And Manufacturing Company | Electrode with pre-wired leads |
JPH08293371A (en) * | 1995-04-20 | 1996-11-05 | Nippon Denki Factory Eng Kk | Ic socket |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1434131A (en) * | 1964-07-31 | 1966-04-08 | Usines Rhone Poulenc Soc D | New acetamidine derivatives |
GB1243186A (en) * | 1967-11-29 | 1971-08-18 | Orsymonde | Improvements in or relating to mandelamidine derivatives |
ZA696719B (en) * | 1968-10-17 | 1971-04-28 | Lilly Co Eli | 13-manphthylacetamidine and salts thereof |
FR2036973A1 (en) * | 1969-04-24 | 1970-12-31 | Orsymonde | |
US3742000A (en) * | 1969-06-03 | 1973-06-26 | Grace W R & Co | Imidoether and amidine derivatives of substituted fatty amides |
JPS5246949B2 (en) * | 1973-10-19 | 1977-11-29 | ||
DD109864A1 (en) * | 1973-11-20 | 1974-11-20 | ||
US3903163A (en) * | 1974-10-02 | 1975-09-02 | Dow Chemical Co | N,N-Disubstituted naphthaleneacetamidines |
JPS5198201A (en) * | 1975-02-18 | 1976-08-30 | n22 chikan omega amijino arufua aminosanjudotaimataha sonosanfukaenno seizoho |
-
1979
- 1979-06-13 IT IT23509/79A patent/IT1121792B/en active
- 1979-06-19 NL NL7904774A patent/NL7904774A/en not_active Application Discontinuation
- 1979-06-28 DK DK273079A patent/DK273079A/en not_active Application Discontinuation
- 1979-06-29 FR FR7917017A patent/FR2430414A1/en active Granted
- 1979-06-29 CA CA330,828A patent/CA1130305A/en not_active Expired
- 1979-07-02 ES ES482113A patent/ES482113A1/en not_active Expired
- 1979-07-02 GB GB7922870A patent/GB2024223B/en not_active Expired
- 1979-07-02 CH CH616579A patent/CH641764A5/en not_active IP Right Cessation
- 1979-07-03 DE DE19792926828 patent/DE2926828A1/en not_active Ceased
- 1979-07-03 BE BE0/196104A patent/BE877449A/en not_active IP Right Cessation
- 1979-07-03 JP JP8437179A patent/JPS559095A/en active Granted
- 1979-07-03 AR AR277173A patent/AR230619A1/en active
Also Published As
Publication number | Publication date |
---|---|
FR2430414A1 (en) | 1980-02-01 |
BE877449A (en) | 1980-01-03 |
IT1121792B (en) | 1986-04-23 |
JPS559095A (en) | 1980-01-22 |
ES482113A1 (en) | 1980-04-01 |
IT7923509A0 (en) | 1979-06-13 |
CH641764A5 (en) | 1984-03-15 |
JPS6343382B2 (en) | 1988-08-30 |
AR230619A1 (en) | 1984-05-31 |
NL7904774A (en) | 1980-01-07 |
GB2024223A (en) | 1980-01-09 |
FR2430414B1 (en) | 1984-06-08 |
GB2024223B (en) | 1982-07-14 |
DE2926828A1 (en) | 1980-01-17 |
DK273079A (en) | 1980-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1130305A (en) | Process for the preparation of n,n'-disubstituted 2-naphthaleneethanimidamide and intermediates used therein | |
CA1223265A (en) | Process for preparing 1,2,4-triazole-3-carboxamides | |
US5461157A (en) | Process for preparing pyrrolidinylacetamide derivatives | |
US4189444A (en) | Process for the preparation of N,N'-disubstituted 2-naphthaleneethanimidamide and intermediates used therein | |
US4017512A (en) | Process for producing N-alkylhydroxylamines | |
KR20010005943A (en) | Process for preparing 0-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides | |
US4731479A (en) | N-sulfamyl-3-halopropionamidines | |
NZ202857A (en) | Preparation of beta-((2-methylpropoxy)methyl)-n-phenyl-n-(phenylmethyl)-1-pyrrolidineethanamine hydrochloride hydrate | |
US6147215A (en) | Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof | |
EP0483674B1 (en) | A process for producing an aliphatic amide and salts thereof | |
HU207718B (en) | Process for producing 3,5,6-trichloropyridin-2-ol | |
AU590128B2 (en) | Synthesis of n-epoxypropyl lactams | |
EP0853077B1 (en) | Process for producing alkyl 3-amino-4-substituted benzoates | |
CA1119179A (en) | Process for preparing n-tritylimidazole compounds | |
KR940009935B1 (en) | N-benzoyl-c-thiophenoxyimidoyl chloride derivatives and manufacturing method thereof | |
US5550288A (en) | Process for the preparation of α-aminoacylanilides | |
US4229375A (en) | 1-Aminomethyltricyclo[4.3.1.12,5 ]undecane and acid-addition salts thereof | |
US5081268A (en) | Process for the preparation of oxetanes from 1,3-glycol monosulfates | |
US2538139A (en) | Biotin derivatives and processes of preparing the same | |
KR950011118B1 (en) | Process for the preparation of organo n-hydroxyimidates | |
US4612395A (en) | Process for the production of N-(2-methyl-4-chlorophenyl)-formamidine derivatives | |
KR960010101B1 (en) | Process for the preparation of 4-orthotolylthio semicarbazides | |
KR860000263B1 (en) | Process for the preparation of di-substituted nitriles from accto nitrile | |
KR920004782B1 (en) | Process for producing of dialkyl 5-fluoro-2,4-dichlorobenzoyl malonate derivatives | |
Yonemoto et al. | Preparation of N-(Substituted formyl) dialkylamino (thioxo) methanesulfenamides. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |